Point: Hyperbaric oxygen is beneficial for diabetic foot wounds

Clinical Infectious Diseases

Volumn 43, Issue 2, 2006, Pages 188-192

  Barnes, Robert C ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTICLE; COST EFFECTIVENESS ANALYSIS; DIABETIC FOOT; FOOT ULCER; HEALTH CARE COST; HUMAN; HYPERBARIC OXYGEN; MAJOR CLINICAL STUDY; PATIENT MONITORING; PATIENT SELECTION; PRIORITY JOURNAL; WOUND HEALING;

CLINICAL TRIALS; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DIABETIC FOOT; HUMANS; HYPERBARIC OXYGENATION; PATIENT CARE; PATIENT SELECTION; WOUND HEALING;

EID: 33745686100     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/505207     Document Type: Article

References (33)

1. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999; 22:382-7.
2. Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care 2003; 26:491-4.
3. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the U.S. Diabetes Care 2003; 26:1790-5.
4. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005; 366:1736-43.
5. Lipsky BA, Berendt AR, Deery HG, et al. IDSA Guidelines: diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004; 39:885-910.
6. American Diabetes Association. Consensus development conference on diabetic foot wound care. Boston, MA. Diabetes Care 1999; 22:1354-60.
7. O'Meara S, Cullum N, Majid M, Sheldon T. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds. 4. Diabetic foot ulceration. Health Technol Assess 2000; 4:1-237.
8. Hunt TK, Pai MP. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet 1972; 135:561-7.
9. Knighton DR, Silver I, Hunt TK. Regulation of wound healing: angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery 1981; 90:262-70.
10. Zhao LL, Davidson JD, Wee SC, Roth SI, Mustoe TA. Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers. Arch Surg 1994; 129:1043-9.
11. Marx RE, Ehler WJ, Tayapongsak P, Pierce LW. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg 1990; 160:519-24.
12. Sheffield PJ. Tissue oxygen measurements. In: Davis JC, Hunt TK, eds. Problem wounds: the role of oxygen. NY: Elsevier, 1988:15-52.
13. Strauss MB, Bryant BJ, Hart GB. Transcutaneous oxygen measurements under hyperbaric oxygen conditions as a predictor for healing of chronic wounds. Foot Ankle Int 2002; 23:933-7.
14. Niinikoski J. Hyperbaric oxygen therapy in diabetic foot ulcers, transcutaneous oximetry in clinical decision making. Wound Repair Regen 2003; 11:458-61.
15. Pecoraro RE, Ahroni JH, Boyko EJ, Stensel VL. Chronology and determinants of tissue repair in diabetic lower-extremity ulcers. Diabetes 1991; 40:1305-13.
16. Fife CE, Buyukcakir C, Otto GH, et al. The predictive value of transcutaneous oxygen tension measurement in diabetic lower extremity ulcers treated with hyperbaric oxygen therapy: a retrospective analysis of 1144 patients. Wound Repair Regen 2002; 10:198-207.
17. Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 1999; 7:335-46.
18. Baroni G, Porro T, Faglia E, et al. Hyperbaric oxygen in diabetic gangrene. Diabetes Care 1987; 10:81-6.
19. Kessler L, Bilbault P, Ortega F, et al. Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic food ulcers. Diabetes Care 2003; 26:2378-82.
20. Abidia A, Laden G, Kuhan G, et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomized-controlled trial. Eur J Vasc Endovasc Surg 2003; 25:513-8.
21. Kranke P, Bennett M, Roeckl-Wiedmann I, Debus S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2004: CD004123.
22. Cianci P, Hunt TK. Long term results of aggressive management of diabetic foot ulcers suggest significant cost effectiveness. Wound Rep Reg 1997; 5:141-6.
23. Kalani M, Jorneskog G, Naderi N, Lind F, Brismar K. Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers: Long-term follow-up. J Diabetes Complications 2002; 16:153-8.
24. Doctor N, Pandya S, Supe A. Hyperbaric oxygen therapy in diabetic foot. J Postgrad Med 1992;38:111, 112-4.
25. Faglia E, Favales F, Aldeghi A, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer: a randomized study. Diabetes Care 1996; 19:1338-43.
26. Otto GH, Buyukcakir C, Fife CE. Effects of smoking on cost and duration of hyperbaric oxygen therapy for diabetic patients with non-healing wounds. Undersea Hyperb Med 2000; 27:83-9.
27. Guo S, Counte MA, Gillespie KN, Schmitz H. Cost-effectiveness of adjunctive hyperbaric oxygen in the treatment of diabetic ulcers. Int J Technol Assess Health Care 2003; 19:731-7.
28. Cianci P, Petrone G, Drager S, Lueders H, Lee H, Shapiro R. Salvage of the problem wound and potential amputation with wound care and adjunctive hyperbaric oxygen therapy. An economic analysis. J Hyperbaric Med 1988; 3:127-42.
29. Clark J. Side effects and complications. In: Feldmeier JJ, ed. Hyperbaric oxygen 2003: indications and results: the hyperbaric oxygen therapy committee report. Kensington, MD: Undersea and Hyperbaric Medical Society, 2003:137-41.
30. Plafki C, Peters P, Almeling M, Welslau W, Busch R. Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med 2000; 71:119-24.
31. Feldmeier J, Carl U, Hartmann K, Sminia P. Hyperbaric oxygen: does it promote growth or recurrence of malignancy? Undersea Hyperb Med 2003; 30:1-18.
32. Undersea and Hyperbaric Medical Society, http://wvvw.uhms.org/Chambers/ CHAMBER%20%DIR%20AS%20OF%204-05.pdf. Accessed 18 December 2005.
33. Rayman G, Krishnan STM, Baker NR, Wareham AM, Rayman A. Are we underestimating diabetes-related lower-extremity amputation rates? Diabetes Care 2004; 27:1892-6.